Cargando…
In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever
Lassa virus (LASV), a member of the Arenaviridae, is an ambisense RNA virus that causes severe hemorrhagic fever with a high fatality rate in humans in West and Central Africa. Currently, no FDA approved drugs or vaccines are available for the treatment of LASV fever. The LASV glycoprotein complex (...
Autores principales: | Baral, Prabin, Pavadai, Elumalai, Gerstman, Bernard S., Chapagain, Prem P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203123/ https://www.ncbi.nlm.nih.gov/pubmed/32376973 http://dx.doi.org/10.1038/s41598-020-63640-1 |
Ejemplares similares
-
A cylindrical assembly model and dynamics of the Ebola virus VP40 structural matrix
por: Pavadai, Elumalai, et al.
Publicado: (2018) -
Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever
por: Rowaiye, Adekunle Babajide, et al.
Publicado: (2022) -
Lassa fever vaccine prospects: identifying immunodominant multi-epitopes as vaccine candidate
por: Nwabueze, Cherechi Omarabia
Publicado: (2023) -
Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion
por: Baral, Prabin, et al.
Publicado: (2021) -
Changes in the receptor-binding interface may cause immune evasion by the SARS-CoV-2 delta variant b.1.617.2
por: Baral, Prabin, et al.
Publicado: (2022)